Meghmani Organics enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,400	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
16.8	16.8	22.7	33.1	61.1
726	726	829	835	820
2,109	—	—	—	—
709	709	806	802	759
₹82.92	—	—	—	—

2,271	2,271	2,344	2,363	2,490
32.0%	32.0%	35.4%	35.3%	33.0%
0.34×	—	—	—	—

1.00×	—	—	—	—
10.16×	—	—	—	—
23.85×	—	—	—	—
11.94×	—	—	—	—
2,103	2,174	2,080	1,566	2,553
207	176	143	−20.3	341
88.4	57.5	34.6	−112	264
—	222	66.2	250	204
177	177	−22.7	−16.5	−261
—	130	−64.1	−24.3	−271
—	45.1	88.9	266	465

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MOL₹55.04

Meghmani Organics Limited

· Chemicals

₹ CrorePeersIPL PUNJABCHEM INSECTICID ASTEC BHARATRAS DHARMAJ GSPCROP ADVANCEMcap ₹1,400 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,399.7
- Cash, Equiv & ST Investments	61.1	33.1	22.7	16.8	16.8
+ Total Debt	820.5	834.9	829.0	726.0	726.0
Enterprise Value	—	—	—	—	2,108.9
Net Debt (memo)	759.4	801.9	806.4	709.1	709.1
EV per Share	—	—	—	—	82.92

Total Capital	2,489.7	2,362.6	2,344.3	2,270.7	2,270.7
Total Debt/Total Capital	32.95	35.34	35.36	31.97	31.97
Total Debt/EV	—	—	—	—	0.34

EV/Sales	—	—	—	—	1.00
EV/EBITDA	—	—	—	—	10.16
EV/EBIT	—	—	—	—	23.85
EV/Free Cash Flow	—	—	—	—	11.94
Reference Items — Trailing FY Values
Sales	2,552.6	1,566.3	2,079.7	2,174.0	2,103.2
EBITDA	341.0	-20.3	142.7	176.4	207.5
EBIT	264.0	-112.5	34.6	57.5	88.4
Operating Cash Flow	204.5	249.7	66.2	221.7	—
Free Cash Flow	-260.7	-16.5	-22.7	176.7	176.7
FCFF (free cash flow to the firm)	-270.8	-24.3	-64.1	130.1	—
Capital Expenditure	465.1	266.2	88.9	45.1	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.